Beyond the above mechanisms, several papers reported the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) as a key positive regulator of PD-L1 expression in cancer [37,38,39] with a key role in regulating macrophage function in tumors [40]. Here, NFKB1 is linked to cancer.